Cowen Raises Price Target on Momenta Phama (MNTA) Following 2Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Goldman Sachs Downgrades Momenta Pharmaceuticals (MNTA) to Neutral
August 6, 2015 6:59 AM EDTGoldman Sachs downgraded Momenta Pharmaceuticals (NASDAQ: MNTA) from Buy to Neutral with a price target of $27 (unchanged).
For an analyst ratings summary and ratings history on Momenta Pharmaceuticals click here. For more ratings news on Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $23.12 yesterday.
... MoreMomenta Pharmaceuticals (MNTA) PT Raised to $26 at Leerink Partners
August 5, 2015 7:58 AM EDTLeerink Partners analyst Jason Gerberry bumped his price target on Outperform-rated Momenta Pharmaceuticals (NASDAQ: MNTA) to $26.00 (from $25.00) following Q2 results.
Gerberry commented, "... MNTA reported better-than-expected top-line revenue of ~$45m vs our est of ~$7m driven by better-than-expected revenue recognition from Glatopa... More
Momenta Phama (MNTA) Reports Q2 Loss Per Share of 4c
August 4, 2015 8:17 AM EDTMomenta Phama (NASDAQ: MNTA) reported Q2 EPS of ($0.04), $0.15 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $44.9 million, may not compare to the consensus estimate of $24.7 million.
Financial Guidance
Today, Momenta provided guidance that it expects its operating expenses, excluding... More
Trading Radar for 8/4: Zillow (Z), Archer Daniels (ADM), Hyatt Hotels (H), Kellogg (K), Sprint (S), Mosaic (MOS) Report
August 3, 2015 3:16 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
A.M. Castle & Co. (NYSE: CAS) - consensus loss $0.48
ALLETE, Inc. (NYSE: ALE) - consensus EPS $0.50
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.54
Abiomed (Nasdaq: ABMD) - consensus EPS $0.08
Aetna (NYSE: AET) - consensus EPS $1.82
Affimed (Nasdaq: AFMD) - consensus loss $0.17
Albany... More
